Learn about BYETTA, the BYETTA Pen. in patients with prior severe hypersensitivity reactions to exenatide or to any of the product components. Patient Information Leaflet. Package leaflet: Information for the patient. Byetta 5 micrograms solution for injection in pre-filled pen. Byetta 10 micrograms solution . Easy to read FDA package insert, drug facts, dosage and administration, and adverse effects for Byetta (Exenatide).
|Published (Last):||17 December 2018|
|PDF File Size:||3.24 Mb|
|ePub File Size:||4.64 Mb|
|Price:||Free* [*Free Regsitration Required]|
The most frequently reported adverse byetta package insert leading to withdrawal for Byetta-treated patients byetta package insert nausea 5. Patients may develop antibodies to exenatide. BYETTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Talk to your healthcare provider first if you are breastfeeding or plan to breastfeed.
Add BYETTA to insulin glargine as a complementary action to help improve glycemic control
Symptoms of a severe allergic reaction include severe rash or packagf, swelling of your face, lips, and throat that byetta package insert cause difficulty breathing or swallowing, feeling faint or dizzy and very rapid heartbeat.
Tell your byetta package insert provider if you have severe problems with your stomach, such as delayed emptying of your stomach gastroparesis or problems with digesting food. Glucagon-like peptide-1 receptor agonist or bolus insulin ihsert optimized basal insulin in type 2 diabetes.
Postmarketing reports of increased international normalized ratio INR sometimes associated with bleeding with concomitant use of warfarin.
Type 2 Diabetes Medication | BYETTA® (exenatide) injection
BYETTA has been associated with acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, based on postmarketing data.
Use with caution in patients with byetta package insert transplantation or when initiating or escalating the dose in patients with moderate renal failure. Write your html here Stop taking BYETTA and packagf your healthcare provider right away if you have pain in byetya stomach area abdomen that is severe, and will not go away, occurs with or without vomiting or is felt going from your abdomen through to your back.
Go to Healthcare Professional Site. Tell your healthcare provider if you are pregnant or plan to become pregnant. No placebo-treated patients withdrew due to nausea or vomiting.
It is unknown whether patients with a history of pancreatitis are at increased risk for pancreatitis while using BYETTA; consider other antidiabetic therapies for these patients. Pen-sharing poses a risk for byetta package insert of blood-borne pathogens, even if the needle is changed.
AstraZeneca provides this link as a service to website visitors. You may give other people bhetta serious infection, or get a serious infection from them. BYETTA is an injectable prescription medicine that may improve blood sugar glucose control in adults with type 2 diabetes, when used with byetta package insert and exercise.
Official BYETTA® (exenatide) injection Healthcare Professional Website
Staying Active Learn how regular physical activity can help you manage type 2 byetta package insert. Not a substitute for insulin and should not be used in patients with type 1 diabetes or byetta package insert ketoacidosis.
To report drug exposure during pregnancy call Your risk for getting low blood sugar hypoglycemia is higher if you take BYETTA with another medicine that can cause low byetta package insert sugar, such as a sulfonylurea or insulin. The most common side effects with BYETTA include nausea, vomiting, diarrhea, feeling jittery, dizziness, headache, acid stomach, constipation, and weakness.
If worsening of or failure to achieve adequate glycemic control occurs, consider alternative antidiabetic therapy. The Double B logo is a trademark of the AstraZeneca group of companies. All other trademarks are byetta package insert of their respective owners. BYETTA should not be used in people with type 1 diabetes or people with diabetic ketoacidosis a condition caused by very high blood sugar.
Should not be used in patients with severe renal impairment or end-stage renal disease. You are encouraged to report negative side effects of prescription drugs to the FDA. Drug Interactions Oral Medications: All other trademarks are property of their respective owners. When used with insulin, evaluate and consider reducing the insulin dose in patients at increased risk of hypoglycemia. Oral medications dependent on threshold concentrations for efficacy, such as contraceptives or antibiotics, should be taken at least 1 hour before BYETTA.
Byetta package insert to Patient Site. Call your healthcare provider right away if you have nausea, vomiting, or diarrhea that will not go away, or if you cannot take liquids by mouth. Use with caution with medications that have a narrow therapeutic index or require rapid gastrointestinal absorption. Before taking BYETTA, tell your healthcare provider if you have had pancreatitis, stones in your gallbladder gallstonesa history of alcoholism, or high blood triglyceride levels.
You may report side effects related to AstraZeneca products by clicking here. This product information is intended for US Healthcare Professionals only. Use of twice-daily byetta package insert in basal insulin—treated patients with type 2 diabetes: The site you are about byetta package insert visit is maintained by a third party who is solely responsible for its contents.
Tell your healthcare provider if you have or had kidney problems or a kidney transplant.
If pancreatitis is suspected, BYETTA should be discontinued promptly and should not be restarted if pancreatitis is confirmed. Byetta package insert of the pancreas pancreatitis may happen, which may be severe and lead to death.
After initiation and dose increases of BYETTA, observe patients carefully for pancreatitis including persistent severe abdominal pain, sometimes radiating byetta package insert the back, with or without vomiting. These may be symptoms of byetta. Based on postmarketing data BYETTA has been associated with acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis.